Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.58B |
| 2 |
iShares MBS ETF
MBB
|
+$1.49B |
| 3 |
RTX Corp
RTX
|
+$839M |
| 4 |
Microsoft
MSFT
|
+$566M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$555M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$1.27B |
| 2 |
Advanced Micro Devices
AMD
|
+$920M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$682M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$567M |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$291M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 11.61% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Integra LifeSciences
IART
$1.38B
| $11.6M | 0.01% |
399,723
+3,529
| +0.9% | +$105K |
|
402
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
| $11.5M | 0.01% |
96,415
+10,489
| +12% | +$1.2M |
|
403
Ameris Bancorp
ABCB
$5.99B
| $11.5M | 0.01% |
227,807
-2,296
| -1% | -$110K |
|
404
Paycom
PAYC
$8.09B
| $11.5M | 0.01% |
80,110
-143,703
| -64% | -$24.6M |
|
405
Ambev
ABEV
$47B
| $11.4M | 0.01% |
5,573,148
-79,548
| -1% | -$181K |
|
406
Affiliated Managers Group
AMG
$10.1B
| $11.1M | ﹤0.01% |
71,280
+3,821
| +6% | +$608K |
|
407
Resideo Technologies
REZI
$3.97B
| $11.1M | ﹤0.01% |
567,756
+51,672
| +10% | +$1.07M |
|
408
Denali Therapeutics
DNLI
$3.85B
| $11.1M | ﹤0.01% |
478,108
+8,939
| +2% | +$172K |
|
409
Manhattan Associates
MANH
$11.1B
| $10.8M | ﹤0.01% |
43,886
-1,373
| -3% | -$311K |
|
410
Atlantic Union Bankshares
AUB
$6.14B
| $10.8M | ﹤0.01% |
328,403
+150
| +0% | +$4.89K |
|
|
CHX
411
DELISTED
ChampionX
CHX
| $10.7M | ﹤0.01% |
323,018
-38,317
| -11% | -$1.31M |
|
412
Pentair
PNR
$11B
| $10.6M | ﹤0.01% |
138,635
+4,621
| +3% | +$372K |
|
413
Cisco
CSCO
$484B
| $10.2M | ﹤0.01% |
215,114
-427,938
| -67% | -$20.3M |
|
414
General Mills
GIS
$19.1B
| $10.2M | ﹤0.01% |
161,504
+42,685
| +36% | +$2.93M |
|
415
Simmons First National
SFNC
$3.48B
| $10.2M | ﹤0.01% |
581,000
| – | – |
|
416
Myriad Genetics
MYGN
$298M
| $9.97M | ﹤0.01% |
407,748
+19,401
| +5% | +$426K |
|
417
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $9.81M | ﹤0.01% |
120,150
-23,696
| -16% | -$1.93M |
|
418
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $9.78M | ﹤0.01% |
214,592
-5,238
| -2% | -$244K |
|
419
Paylocity
PCTY
$7.72B
| $9.73M | ﹤0.01% |
73,806
+961
| +1% | +$149K |
|
420
Bankunited
BKU
$3.45B
| $9.63M | ﹤0.01% |
329,000
| – | – |
|
421
First Solar
FSLR
$25.5B
| $9.59M | ﹤0.01% |
42,556
+122
| +0.3% | +$26.6K |
|
422
Invesco NASDAQ 100 ETF
QQQM
$102B
| $9.59M | ﹤0.01% |
48,659
-3,417
| -7% | -$632K |
|
423
West Pharmaceutical
WST
$24.6B
| $9.48M | ﹤0.01% |
28,774
+48
| +0.2% | +$17K |
|
424
Bristol-Myers Squibb
BMY
$130B
| $9.47M | ﹤0.01% |
227,998
+2,245
| +1% | +$100K |
|
425
Associated Banc-Corp
ASB
$5.96B
| $9.39M | ﹤0.01% |
444,000
-24
| -0% | -$505 |
|
Similar funds
Ken Fisher's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Fisher held 1,069 positions worth $230B, up 7.4% from $214B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Fisher deployed $7.03B of net new capital in Q2 2024, opening 105 new positions and adding to 492 existing holdings. Its largest new stake was ZTO Express: 3,166,868 shares worth $65.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $1.27B trimmed.
- Ken Fisher's largest Q2 2024 buy was ZTO Express: 3,166,868 shares worth $65.7M.
- Ken Fisher added most to Canadian Natural Resources in Q2 2024, an estimated $1.58B increase.
- Ken Fisher's biggest Q2 2024 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $1.27B.
- Ken Fisher fully exited Thor Industries in Q2 2024, selling an estimated $24.5M.
- Ken Fisher's ten largest holdings make up 34% of its $230B portfolio in Q2 2024.
- Ken Fisher opened 105 new positions and closed 83 in Q2 2024.
- Ken Fisher's portfolio value rose 7.4% quarter-over-quarter to $230B.
Based on Fisher Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.